Hiscox Ltd Overview
Hiscox is a Bermuda-headquartered, London-listed pure-play specialty insurer. It runs a deliberately balanced portfolio that pairs low-volatility, compounding retail specialty insurance with cyclical, catastrophe-exposed big-ticket and reinsurance underwriting.
Hiscox Retail is the group's largest and fastest-compounding engine at $2.63bn ICWP in FY2025. It sells specialist commercial and personal lines to small businesses, professionals and high-net-worth individuals in the UK, Europe and the US. Distribution runs through brokers, partners and direct digital channels.
Hiscox London Market (Lloyd's Syndicate 33) and Hiscox Re (including the newly branded Hiscox Capital Partners ILS platform) provide high-margin specialty, property and reinsurance exposure. They are actively managed through the underwriting cycle.
The model delivered three consecutive years of record pre-tax profit to FY2025 ($732.7m). It also produced a decade-best undiscounted combined ratio of 87.8% and operating ROTE of 20.9%. Hiscox is now executing a $200m efficiency programme and a target of double-digit retail growth by 2028. It is also the subject of unconfirmed takeover speculation involving Intact Financial.
Company's own description
In its FY2025 and H1 2026 releases, Hiscox describes itself as a global specialty insurer headquartered in Bermuda and listed on the LSE. Its stated ambition is to remain among the world's most respected specialist insurers, with a portfolio diversified by product and geography.
Its core philosophy is balance. Catastrophe-exposed business is paired with less volatile local specialty business to create profitable growth opportunities throughout the insurance cycle. In its own framing:
-
The retail businesses in the USA, UK and Europe offer specialist commercial and personal lines.
-
Internationally traded, bigger-ticket business and reinsurance are written through Hiscox London Market and Hiscox Re.
Independent characterisation
Hiscox operates as a three-engine specialty (re)insurer with a capital-light fee overlay.
1. Hiscox Retail — the compounder.
-
Writes small-ticket, high-volume specialist lines: professional indemnity, small-business liability, cyber, high-net-worth home and contents, and fine art.
-
Sells through brokers, partners/affinity relationships and direct-to-consumer digital channels ("DPD": direct and partnerships distribution in the US).
-
Hiscox claims a 20-year unbroken record of compounding premium growth in Retail (H1 2026 release).
-
Growth is volume-led: policy count growth is outpacing rate, and retail rates rose only about 1% in H1 2026.
-
Strategic weight is shifting toward Retail. It is the main beneficiary of the $200m change programme and the double-digit growth ambition.
2. Hiscox London Market — the cycle manager.
-
Big-ticket specialty written through Lloyd's Syndicate 33.
-
Lines include major property, marine and energy, kidnap and ransom, war, terrorism and political violence, and product recall.
-
Rates are now falling (-5% in H1 2026) from a generational peak (+59% cumulative since 2018). Hiscox is shrinking selectively; for example, it non-renewed 23% of its power and renewables book.
3. Hiscox Re & Hiscox Capital Partners — risk-taker and asset gatherer.
-
Property catastrophe, specialty and pro-rata reinsurance written from Bermuda, London and Paris.
-
Paired with a third-party capital platform: ILS funds, cat bond funds and quota-share partners.
-
ILS assets under management rose from $1.5bn (1 Jan 2026) to $2.9bn (1 Jul 2026).
-
Fee income reached $53m in H1 2026. Hiscox Re is reducing net exposure while growing gross via partner capital, a structural shift toward fee-earning, capital-light reinsurance.
Revenue model
| Revenue type | Description | Approx. share (FY2025) |
|---|---|---|
| Insurance revenue (earned premium, IFRS 17) | Core underwriting revenue across all three segments | $4,883.7m insurance revenue (five-year summary, FY2025) |
| Investment result | Return on c.$9.3bn of financial assets and cash | $442.7m (FY2025) |
| Third-party capital fees | ILS management and performance fees; quota-share overriding commissions | $109.4m fee income in FY2025 (2024: $128.2m). $53m in H1 2026 alone. |
| Product / subscription / licensing | Not applicable. Hiscox does not sell software or licences. | — |
Value-chain position
Hiscox is a risk carrier and underwriter. It is not a broker or distributor of third-party products, although it owns direct digital distribution in the US, UK and Europe. It sits between:
-
Distribution (brokers, MGAs, affinity partners, digital marketplaces)
-
Capital providers (shareholders, ILS investors, reinsurers)
It buys outward reinsurance and retrocession, and through Hiscox Re it also sells reinsurance to other carriers.
Customer types and end-markets
| Segment | Customer types | End-markets |
|---|---|---|
| Retail – UK, Europe, USA | Micro-businesses, SMEs, professionals (consultants, IT contractors, architects, accountants; new 2026 appetite for forensic scientists, food technologists, podcasters, online tutors); high-net-worth households; art collectors | UK, Ireland, Germany, France, Netherlands, Belgium, Spain, Portugal and other European markets (ten European markets per FY2025 release); USA |
| London Market | Corporates, energy companies, shipowners, multinationals, specialty buyers via Lloyd's brokers | Global |
| Hiscox Re | Insurance companies (cedants), governments / emerging-market climate-resilience buyers (parametric), mortgage and surety markets | Global, with US property catastrophe as the largest peril region (inferred from LA wildfire exposure) |
| Hiscox Capital Partners | Institutional ILS investors (pension funds, endowments, asset managers) | Global investors |
Strategy
Stated strategy (themes from FY2025 Report and May 2025 Capital Markets Day)
| Change programme phasing (USD Mn) | FY2025 | FY2026 | FY2028 |
|---|---|---|---|
| Target P&L benefit | 29 | 75 | 200 |
Overarching aim: Deliver attractive and sustainable shareholder returns by exploiting the group's diversified business model, differentiated exposure to specialty markets and specialist technical capabilities.
Addressable market: Hiscox sizes its annualised target addressable market at $317bn.
Retail growth ambition: Accelerate Retail ICWP growth to double digits by 2028 by gaining share in sizeable serviceable addressable markets. The path is 6.3% (2025), then 8% guidance for 2026, upgraded to 9% in August 2026.
Change programme: An annualised $200m P&L benefit from 2028 against a 2024 baseline, with a $200m cost to achieve. Most of the benefit falls in Retail, across claims, attributable expenses and non-attributable expenses.
Actuals to date: $29m delivered in FY2025; $45m delivered in H1 2026 at a cost of $39m.
Big-ticket cycle management: London Market and Re are managed through the cycle, shrinking net exposure where rates are inadequate.
Capital efficiency: - Operate within a BSCR range of 190–200%.
-
Progressive dividend per share after a 20% step-up in the final FY2025 DPS (delivered: 35.9¢).
-
Recurring buybacks from surplus capital.
Technology and AI: Hiscox describes AI-enabled operational capabilities driving productivity gains and operating leverage. Examples:
-
AI-assisted lead underwriting in terrorism
-
AI submission triage in art and private client
-
Digital direct quote-and-bind in the US
Strategic initiatives (last 24 months)
| Initiative | Date | Detail |
|---|---|---|
| Capital Markets Day targets | May 2025 | Double-digit Retail growth by 2028; $200m change programme; BSCR range; dividend step-up |
| Change programme execution | 2025–2028 | $29m (2025), $45m (H1 2026); tracking ahead of linear phasing |
| Product acceleration | 2,025 | More product launches in 2025 than in the previous five years combined (CEO, FY2025) |
| European cyber rollout | H1 2026 | Cyber product extended from France and Germany to all European markets |
| New UK/Retail appetite | H1 2026 | Forensic scientists, food technologists, podcasters, online tutors |
| Hiscox Capital Partners launch | 2,026 | Consolidates third-party capital and ILS under one brand. AUM up 93% year-to-date to $2.9bn. |
| Climate and resilience capability (Hiscox Re) | 2,025 | Parametric products for emerging markets |
| Distribution deals | 2023–2026 | Partnerships signed over three years now reaching scale |
| Revenue and marketing leadership | Jul 2026 | New Group CMRO role to drive customer-led growth |
| DirectAsia exit | 2,025 | Completes withdrawal from Asian direct motor |
| Buyback programmes | 2025, 2026 | $175m (2025), $300m (2026) |
Medium-term guidance (current)
| Metric | Guidance |
|---|---|
| Hiscox Retail ICWP growth (constant currency) | 9% for FY2026 (upgraded from 8% on 5 Aug 2026); double digits by 2028 |
| Hiscox Retail undiscounted combined ratio | Within an 89–94% operating range, improving gradually within it |
| Change programme benefit | $75m (2026); $200m annualised (2028 onward) |
| Group returns | Through-the-cycle mid-teens ROTE |
| Capital | Operate within 190–200% BSCR |
| Dividend | Progressive DPS. Interim set at one-third of prior-year total. |
The ROTE target was exceeded in FY2025 (20.9%) and in H1 2026 (20.2%).
Products & Services
Pricing is not publicly disclosed for any line. Hiscox prices per risk, and US and UK small-business products are quoted online.
Hiscox Retail — Hiscox UK (FY2025 ICWP $962.4m, +8.4% constant currency)
| Product / brand | Description | Target customer | Notes |
|---|---|---|---|
| Professional indemnity | Liability cover for errors and omissions | Consultants, IT, marketing, design, finance professionals | Historic UK franchise core; sold direct and via brokers |
| Small business / SME commercial combined | Public liability, employers' liability, property, business interruption | Micro and small businesses | Growth driven by distribution deals, brand investment and sector specialisms (Q1 and H1 2026) |
| Cyber and data risks | First- and third-party cyber, breach response | SMEs | Hiscox publishes an annual Cyber Readiness Report (brand asset) |
| Private client / high-net-worth home | Buildings, contents, valuables, art | High-net-worth individuals | UK Private Client grew double digits in 2025 (FY2025 call). NPS above 80 cited in H1 2026 call. |
| Fine art and specie | Art collections, collectors, galleries | Collectors and institutions | Moved into Retail reporting from FY2025. AI tool cut review time of priority submissions from 2.5 days to 2.5 hours (2024). |
| New 2026 appetite | Niche professional classes | Forensic scientists, food technologists, podcasters, online tutors | Added in H1 2026 |
Hiscox Retail — Hiscox Europe (FY2025 ICWP $710.9m, +6.1% constant currency)
| Product | Description | Markets | Notes |
|---|---|---|---|
| Professional liability / D&O | Specialist liability for professionals and management | Germany, France (largest markets) plus others | Germany is the "flagship of Europe" (management bio of R. Dietrich) |
| Cyber | SME cyber product | First launched in France and Germany; rolled out across all European markets in H1 2026 | — |
| Art and private clients | High-value home, art | Pan-European | — |
| Direct-to-consumer and technology lines | Digital direct and tech E&O | Germany-led | — |
European operating markets in the FY2025 release total ten; country websites include Germany, France, Netherlands, Belgium, Spain, Portugal and Ireland.
Hiscox Retail — Hiscox USA (H1 2026 ICWP $535.9m, +8.1%)
| Channel / product | Description | Notes |
|---|---|---|
| Digital direct (DPD) | Online quote-and-bind small-business insurance: general liability, professional liability, business owner's policies | US DPD grew 7.0% in FY2025. Digital direct delivered record premium in H1 2026. |
| Partnerships | Embedded and affinity distribution through partners | Part of DPD. Distribution deals take around 18 months to scale (H1 2026 call). |
| US broker | Specialty small-commercial via retail and wholesale brokers | Returned to growth: +0.7% FY2025, +1.5% Q1 2025 |
| FloodPlus | Private flood insurance, an alternative to the NFIP | Launched 2016 |
| Cyber | Small-business cyber | Part of the US product set |
Hiscox London Market (FY2025 ICWP $1,249m; Syndicate 33)
| Line | Description | 2025–26 stance |
|---|---|---|
| Major property / US property D&F | Large commercial property | Selective; rates softening |
| Power and renewables | Energy transition and power assets | 23% of book non-renewed in H1 2026 on rate inadequacy |
| Marine, energy and specialty | Hull, cargo, energy | Grew in Q1 2025 |
| War, terrorism and political violence | Including AI-assisted terrorism lead underwriting (from 2024) | Middle East loss of $40m in H1 2026 (with marine war and K&R) |
| Kidnap and ransom | Special risks | — |
| Product recall | — | Exposure being reduced (H1 2026 call) |
| Cyber / D&O / large binders | Financial lines | Reduced in 2024 cycle management |
| Space | — | Ceased (2024) |
Cumulative London Market rate change was +59% since 2018 at H1 2026, after -4% in 2025 and -5% in H1 2026.
Hiscox Re & Hiscox Capital Partners
| Offering | Description | Notes |
|---|---|---|
| Property catastrophe reinsurance | Excess-of-loss cat cover for cedants | Rates: -5% in 2025, -13% at 1 Jan 2026, -16% across H1 2026. Net cat exposure being reduced. |
| Specialty and pro-rata | Quota share and specialty classes | Growth driver in 2025 |
| Parametric climate resilience | Parametric covers for emerging-market and climate-resilience buyers | Capability developed in 2025 |
| Mortgage and surety | Specialty reinsurance lines | Growth lines (FY2025) |
| Hiscox Capital Partners – ILS funds | Managed ILS strategies, bespoke mandates and managed accounts | AUM $1.5bn (1 Jan 2026) → $2.4bn (1 Apr 2026) → $2.9bn (1 Jul 2026) |
| Cat bond funds | Catastrophe bond strategies | $1.0bn of the $1.4bn gross H1 2026 inflows went into cat bond funds (Artemis) |
| Quota-share partnerships | Third-party capital sharing Hiscox Re's portfolio | FY2025 fee income from ILS and QS partners: $109.4m |
Financial Narrative
Note on standards. FY2021 is reported under IFRS 4/IAS 39 and is not directly comparable. FY2022 onward is IFRS 17 (restated).
Income statement
Sources: Hiscox five-year summary (website, unaudited); FY2025 preliminary results.
-
FY2021 figures are IFRS 4 and were corrected for transposition on the company site.
-
FY2023 PAT includes a $150m deferred tax credit related to the Bermuda ETA.
-
Gross profit and EBITDA are not reported by Hiscox and are not meaningful for an insurer.
Margins and growth (derived)
Sources: undiscounted combined ratios per Hiscox filings as reported by Insurance Business (Feb 2026). The FY2021 combined ratio is on the IFRS 4 basis.
Insurance revenue CAGR FY2022–FY2025 (derived): 4.5% per year.
Commentary.
Profitability inflection: FY2022 was the inflection year. PBT more than doubled from $275.6m to $625.9m in FY2023 as:
-
the hard market earned through London Market and Re;
-
higher bond yields lifted the investment result;
-
Retail margins began to expand after the 2019–2020 US casualty and COVID BI issues.
Steady compounding since: PBT grew +9.5% in FY2024 and +6.9% in FY2025.
Tax drag on net income: The rising effective tax rate depresses PAT. Bermuda introduced a 15% corporate income tax from 2025. Management cites a 2.5-percentage-point drag on FY2025 operating ROTE. This is why PAT fell in FY2025 despite record PBT, and why ROE declined from 19.8% to 17.1%.
Reserve releases: FY2025's underwriting result was materially supported by $292.7m of positive prior-year development, double the FY2024 level. Releases spanned all accident years 2021–2024. This is a quality-of-earnings point: releases of this size are unlikely to recur indefinitely as softening rates feed into new accident years.
Balance sheet
Sources and caveats:
-
Hiscox five-year summary (FY2021 insurance liabilities are on the IFRS 4 basis).
-
H1 2026 NAV per share: 1,234.9¢.
-
Total assets were not captured in this research.
-
See the debt investor page and the 2025 Report and Accounts.
NAV per share CAGR FY2021–FY2025 (derived): about 13.3% per year, before dividends.
Commentary.
Investment portfolio growth: The portfolio grew about 27% over four years to $9.3bn. Cash was redeployed into fair-value assets: cash fell from $1.44bn (2023) to $0.88bn (2025) while financial assets rose $1.86bn. This lifts recurring yield ("earn-through of higher coupons").
Goodwill and intangibles: The rise to $381.0m in FY2025 (+$72m) is consistent with capitalised technology investment under the change programme. Hiscox does not undertake large acquisitions.
Capital surplus: Equity growth has been tempered by heavy capital return. The BSCR still rose to 233% (FY2025 estimate) from 229%, well above the 190–200% operating range. That surplus funds the buybacks.
Cash flow and capital return
Notes on capital return:
-
Operating cash flow and capex were not captured from the cash flow statement; the primary PDF was not machine-accessible.
-
The FY2025 programme ($175m) was launched with the FY2024 results in February 2025.
-
The FY2026 programme ($300m) was announced on 25 Feb 2026. It was 32% complete at 30 June 2026, with completion expected before the FY2026 results.
-
Cumulative dividends and buybacks announced over three years exceed $1.1bn (FY2025 results).
Return and leverage ratios
Ratio notes:
-
The FY2025 BSCR is an estimate.
-
H1 2026 adjusted operating ROTE (annualised) was 20.2%, against 14.5% in H1 2025.
-
Current ratio, net debt/EBITDA, asset turnover and cash conversion cycle are not meaningful for an insurer.
-
ROA, ROIC, debt/equity and interest coverage cannot be computed without verified total assets, borrowings and finance costs.
Interim 2026 snapshot
Commentary.
Headline vs underlying: The reported PBT decline is driven by a net fair value loss on financial assets of $78.4m, against a $61.1m gain in H1 2025. Management expects these unrealised losses on fixed-income securities to unwind as the bonds mature.
Underwriting strength: The underlying picture is materially stronger: ISR +30%, adjusted operating PBT +26%, and a 220bp better combined ratio.
Change programme: The programme delivered a $45m P&L benefit in H1 against $39m cost to achieve. It is on track for $75m in FY2026 and $200m in 2028.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Income Statement and Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Insurance revenue (USD Mn) | — | 4,273.3 | 4,483.2 | 4,672.5 | 4,883.7 |
Insurance contract written premium (USD Mn) | — | — | — | 4,703.7 | 4,979.0 |
Net ICWP (USD Mn) | — | — | — | 3,622.4 | 3,865.8 |
Insurance service result (USD Mn) | — | — | — | 553.5 | 613.9 |
Investment result (USD Mn) | — | — | — | 383.9 | 442.7 |
Positive prior-year development (USD Mn) | — | — | — | 145.5 | 292.7 |
Adjusted operating profit before tax (USD Mn) | — | — | — | 683.3 | 743.8 |
Profit before tax (USD Mn) | 190.8 | 275.6 | 625.9 | 685.4 | 732.7 |
Profit after tax (USD Mn) | 189.5 | 253.9 | 712.0 | 627.2 | 604.1 |
Basic EPS (US cents) | 55.3 | 73.8 | 206.1 | 183.2 | 180.7 |
Diluted EPS (US cents) | 54.7 | 72.7 | 201.5 | 178.1 | 175.0 |
Adjusted operating EPS (US cents) | — | — | — | 184.4 | 183.9 |
Dividend per share (US cents) | 34.5 | 36.0 | 37.5 | 43.1 | 50.3 |
Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Pre-tax margin on insurance revenue (%) | — | 6.4 | 14.0 | 14.7 | 15.0 |
Net margin on insurance revenue (%) | — | 5.9 | 15.9 | 13.4 | 12.4 |
Effective tax rate (%) | 0.7 | 7.9 | -13.8 | 8.5 | 17.6 |
Insurance revenue growth (%) | — | — | 4.9 | 4.2 | 4.5 |
Undiscounted group combined ratio (%) | — | 90.6 | 89.8 | 89.2 | 87.8 |
Discounted group combined ratio (%) | 93.2 | 88.7 | 85.5 | 84.7 | 83.7 |
Dividend payout ratio on basic EPS (%) | 62.4 | 48.8 | 18.2 | 23.5 | 27.8 |
Balance Sheet and Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Goodwill and intangible assets (USD Mn) | 313.1 | 320.4 | 323.9 | 308.8 | 381.0 |
Financial assets at fair value (USD Mn) | 6,041.3 | 5,812.1 | 6,574.4 | 7,077.6 | 8,432.0 |
Cash and cash equivalents (USD Mn) | 1,300.7 | 1,350.9 | 1,437.0 | 1,227.0 | 878.0 |
Total investments plus cash (USD Mn, derived) | 7,342.0 | 7,163.0 | 8,011.4 | 8,304.6 | 9,310.0 |
Insurance liabilities net of reinsurance assets (USD Mn) | -4,690.4 | -4,177.1 | -4,505.7 | -4,419.5 | -5,052.7 |
Other net assets / (liabilities) (USD Mn) | -155.4 | -671.3 | -532.9 | -504.0 | -690.5 |
Net assets / shareholders' equity (USD Mn) | 2,539.3 | 2,635.0 | 3,296.7 | 3,689.9 | 3,947.9 |
Tangible net assets (USD Mn, derived) | 2,226.2 | 2,314.6 | 2,972.8 | 3,381.1 | 3,566.9 |
Net asset value per share (US cents) | 739.8 | 764.5 | 951.5 | 1,086.4 | 1,220.0 |
Dividends & Capital Returns
| Metric | FY2025 |
|---|---|
Share buybacks announced (USD Mn) | 175 |
Returns & Leverage Ratios (%)
| Ratio | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Return on equity (%) | 8.1 | 10.1 | 27.6 | 19.8 | 17.1 |
Operating return on tangible equity (%) | — | — | — | 24.1 | 20.9 |
BSCR (%) | — | — | — | 229 | 233 |
Per-Share Data
| Metric | H1 2025 | H1 2026 | Change |
|---|---|---|---|
ICWP | 2,941.6 | 3,238.4 | +10.1% |
Net ICWP | 2,125.2 | 2,269.3 | +6.8% |
Insurance service result | 196.2 | 255.4 | +30.2% |
Investment result | 234.9 | 128.2 | -45.4% |
Profit before tax | 276.6 | 240.5 | -13.1% |
Adjusted operating PBT | 262.0 | 331.0 | +26.3% |
EPS (¢) | 67.2 | 82.3 | +22.5% |
Adjusted operating EPS (¢) | 63.9 | 105.2 | +64.6% |
Interim DPS (¢) | 14.4 | 16.8 | +16.7% |
NAV per share (¢) | 1,133.3 | 1,234.9 | +9.0% |
Revenue by Region
| Retail region ICWP (USD Mn) | FY2024 | FY2025 |
|---|---|---|
Hiscox UK (incl. Ireland) | 864.0 | 962.4 |
Hiscox Europe | 656.5 | 710.9 |
Hiscox USA (residual, derived) | 920.5 | 960.7 |
Retail Region Details
| Retail region | FY2025 growth (constant currency) | Main drivers |
|---|---|---|
Hiscox UK | +8.4% | Strong double-digit new-business growth |
Hiscox Europe | +6.1% | Germany and France |
Hiscox USA | DPD +7.0%; broker +0.7% | DPD led by digital direct |
Revenue by Region (Q1 2025–H1 2026)
| Region ICWP (USD Mn) | Q1 2025 | Q1 2026 | H1 2025 | H1 2026 |
|---|---|---|---|---|
Hiscox UK | — | — | 463.4 | 530.2 |
Hiscox Europe | 273.5 | 328.2 | 427.2 | 494.6 |
Hiscox USA | 253.2 | — | 496.0 | 535.9 |
Retail total | 736.1 | 847.2 | 1,390.0 | 1,560.7 |
London Market | 329.7 | 342.8 | — | 733.2 |
Hiscox Re | 492.2 | 527.1 | 887.3 | 944.5 |
Geographic Revenue
| Region | Q1 2026 | H1 2026 |
|---|---|---|
Hiscox UK | +8.9% | +10.2% |
Hiscox Europe | +6.8% | +6.2% |
Hiscox USA | +8.5% | +8.1% |
Retail total | +8.0% | +8.2% |
Share price (GBp)
| Share price (GBp) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Annual high | 1,004.0 | 1,106.5 | 1,193.0 | 1,281.0 | 1,454.0 |
Annual low | 770.0 | 827.2 | 938.0 | 998.0 | 1,022.0 |
Performance Details
| Performance | Value | Basis |
|---|---|---|
1-year | About +45–51% | Börse Stuttgart 1-year performance of +50.6% (2 Sep 2026); 52-week low about 1,288p versus 1,867p now |
3-year | Approximately +75–90% | Illustrative, from the 2023 trading range (938–1,193p); not exact |
5-year | Approximately +100–130% | Illustrative, from the 2021 trading range (770–1,004p); not exact |
Peak | Record high in May 2026 on Intact reports | — |
Valuation Multiples
| Multiple | Hiscox | Notes |
|---|---|---|
P/E (TTM) | About 13.2–13.3x | Aggregator data (Aug–Sep 2026). Börse Stuttgart shows 10.4x on a different EPS basis. |
P/B | About 2.0x (illustrative) | H1 2026 NAV of 1,234.9¢ per share, converted at an assumed USD/GBP of 1.33, against a 1,867p share price. |
EV/EBITDA, EV/Sales | Not meaningful for insurers | — |
Dividend yield | About 2.05–2.08% | Aggregators (Sep–Oct 2026) |
Peer reference | Zurich/Beazley takeover at 1,335p per share | Strategic multiple benchmark |
Analyst Ratings & Targets
| Broker | Date | Rating | Target |
|---|---|---|---|
Barclays | 4 Sep 2026 | Overweight | 2,030p (from 1,820p) |
Unnamed (investing.com feed) | 4 Sep 2026 | Buy | 2,030p |
Unnamed | 7–10 Aug 2026 | Buy | 2,150p |
Unnamed | 6 Aug 2026 | Hold | 1,846p |
Unnamed | 5 Aug 2026 | Buy | 2,050p |
RBC Capital Markets | 26 Feb 2026 | Raised target | Not captured |
Jefferies | — | Double downgrade to Underperform | Not captured |
Dividend (US cents)
| Dividend (US cents) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Total DPS | 34.5 | 36.0 | 37.5 | 43.1 | 50.3 |
Final DPS | — | — | — | 29.9 | 35.9 |
Credit Ratings
| Agency | Entity | Rating | Outlook |
|---|---|---|---|
AM Best | Hiscox Insurance Co (Bermuda), Hiscox Insurance Co Ltd (UK), Hiscox Insurance Co (Guernsey), Hiscox Insurance Co Inc (US) | FSR A (Excellent); ICR a+ | Not captured |
AM Best | Hiscox Ltd (holding company) | ICR bbb+ | Not captured |
AM Best | Lloyd's Syndicate 33 | FSR A; ICR a+ (historical affirmation) | — |
S&P | Hiscox operating entities | — | — |
Moody's | Hiscox Ltd | — | — |
Fitch | Hiscox Ltd | — | — |
Analyst Conclusions
Management guidance (5 Aug 2026)
-
Outlook described as "positive".
-
FY2026 Retail ICWP growth of 9% constant currency, upgraded from 8%, with double digits by 2028.
-
Retail undiscounted COR improving gradually within 89–94%.
-
Change programme: $75m in 2026 and $200m in 2028.
-
Through-the-cycle ROTE in the mid-teens. Actual performance is running at about 20%.
-
Completion of the $300m buyback before FY2026 results.
-
Continued cycle management in big-ticket, with net cat exposure reducing at Hiscox Re.
Consensus expectations
Detailed consensus EPS and premium forecasts were not available from primary sources. The sell-side tone after the H1 results was predominantly Buy/Overweight, with targets clustered at 1,850–2,150p. One notable bear is Jefferies (Underperform).
Bull case
-
Retail mix shift drives quality compounding. Retail growth is accelerating (6.3%, then 8.2% in H1, then 9% guidance) toward double digits. Combined with $200m of change benefits, mostly in Retail, this could take Retail PBT well above FY2025's $352m. Earnings would become less cyclical and could justify a re-rating.
-
Capital-light fee engine. Hiscox Capital Partners AUM is $2.9bn, nearly doubled year-to-date. H1 fee income of $53m is already half of FY2025's $109m. The fee line can offset big-ticket softening.
-
Strategic scarcity and M&A floor. Beazley's sale to Zurich and Intact's reported interest establish a strategic valuation framework. A 233% BSCR also supports ongoing buybacks of about 5% of the share count per year.
Bear case
-
Big-ticket margins have peaked. London Market rates fell 5% and Re rates 16% in H1 2026. London Market's COR has already deteriorated to 93.8% (from 87.9%). Re's 60s combined ratios are unlikely to persist.
-
Reserve releases and investment marks flatter results. FY2025 PYD of $292.7m (about 40% of PBT) cannot be repeated indefinitely. The H1 2026 fair-value loss of $78.4m shows how sensitive reported earnings are to rates. Bermuda CIT permanently lowers ROE.
-
Speculative premium. The shares hit records on unconfirmed Intact reports. Without a bid, valuation at about 13x P/E and about 2x book may compress toward peers, especially if H2 2026 brings meaningful hurricane losses.
Key catalysts and monitorables (next 12 months)
| Catalyst | Timing |
|---|---|
| Q3 2026 trading statement (Retail growth versus 9%; Re net exposure; H2 cat losses) | Late Oct / early Nov 2026 |
| Any Takeover Code announcement involving Intact or another bidder | Any time |
| 1 Jan 2027 reinsurance renewals (rate trajectory; ILS inflows) | Jan 2027 |
| FY2026 results: change benefit versus $75m; PYD level; FY2027 Retail guidance; new buyback size | Expected 3 Mar 2027 (aggregator calendar) |
| Board refreshment (NEDs reaching nine years in Nov 2026) | 2026–27 |
| Q1 2027 trading statement | May 2027 |
| 2027 AGM and 2026 Directors' Remuneration Report | Spring 2027 |
Concluding analyst verdict
Hiscox enters late 2026 in the strongest operational position of its modern history.
It has delivered three consecutive record pre-tax profits, culminating in $732.7m in FY2025, and a decade-best 87.8% undiscounted combined ratio. H1 2026 added double-digit premium growth and a 20.2% adjusted operating ROTE, with both a $60m Middle East loss and significant fair-value investment losses absorbed. The equity story has clearly pivoted. Hiscox is no longer primarily a Lloyd's and reinsurance cycle play. It is a retail specialty compounder with a cyclical, increasingly fee-based big-ticket overlay.
The key analytical tension is timing. Retail is accelerating just as big-ticket pricing softens: London Market rates fell 5% and Re rates 16% in H1 2026, and London Market's combined ratio has already moved into the 90s. Group earnings growth over 2027–2028 therefore depends on three things:
-
Retail delivering 9–10%+ growth at stable or improving margins;
-
the change programme hitting its $200m benefit;
-
Hiscox Capital Partners converting rapid AUM growth into durable fees.
The early evidence on all three is encouraging. The $45m H1 change benefit is ahead of linear phasing, Retail guidance has been upgraded, and ILS AUM has nearly doubled.
Offsetting this, reported earnings remain flattered by large reserve releases and are exposed to bond marks, catastrophe activity and a permanently higher Bermuda tax rate. The share price, near record levels at about 1,867p, already embeds some takeover optionality from the unconfirmed Intact reports.
Verdict: a high-quality, well-capitalised specialty franchise with credible self-help and capital-return support. Fundamentals justify a constructive stance. However, the risk-reward at current levels is more balanced than a year ago. The next 12 months hinge on hurricane-season outcomes, Q3 Retail momentum, the 1 January 2027 renewals and any formal M&A development. Investors should monitor PYD normalisation and London Market margins as the principal downside indicators.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Title | Joined / in role | Prior roles | Education |
|---|---|---|---|---|
Aki Hussain | Group CEO (Executive Director) | Joined 2016 as Group CFO; CEO since Jan 2022 | Prudential plc (CFO Prudential UK & Europe); FD Consumer Bank, Lloyds Banking Group; FD Consumer, ntl (Virgin Media) | Chartered Accountant (trained at KPMG) |
Paul Cooper | Group CFO (Executive Director) | May 2022 | Interim Group CFO M&G plc; CFO Prudential Assurance Co.; Group CFO Canopius; Group CFO Arrow Global; FD Hiscox Insurance Co.; Partner EY; ABI board member | BA Economics (Manchester); Chartered Accountant (PwC) |
Joanne Musselle | Group Chief Underwriting Officer | Joined 2002; Group CUO since end-2019 | AXA, Aviva (UK and Asia); Hiscox UK claims, UK CUO, Retail CUO | — |
Fabrice Brossart | Group Chief Risk Officer | Nov 2023 | AIG (CRO International General Insurance); AXA Insurance UK (Chief Actuary) | Actuary |
Shali Vasudeva | Group Chief Operations & Technology Officer | Jan 2025 | COO AXA UK & Ireland (five years) | — |
Aparna Sarin | Group Chief Marketing & Revenue Officer (new role) | Jul 2026 | CMO Business Cards & Payments, Capital One; American Express | — |
Nicola Grant | Chief People Officer | Sep 2022 | 17 years at ING Group | — |
Shirley Girling | Group General Counsel | 2026 | WTW (GC Risk & Broking); AXA; Capita; private practice | Solicitor (England & Wales) |
Marc Wetherhill | Company Secretary | 2017 | PartnerRe (Chief Legal Counsel); Appleby | Solicitor; Bermuda Bar (2001) |
Mary Boyd | CEO, Hiscox USA | 2024 | CEO independent agency business, Plymouth Rock; SVP The Hartford; President Private Risk Services, Chubb | Began as an actuarial trainee |
Robert Dietrich | CEO, Hiscox Europe | Mar 2021 (joined 1997) | MD Hiscox Germany (15 years) | — |
Jon Dye | CEO, Hiscox UK | Sep 2022 | CEO Allianz UK (eight years); Chair ABI 2019–21; Chubb, Commercial Union | Law (Cambridge); FCII |
Kate Markham | CEO, Hiscox London Market | 2017 (joined 2012) | Head of UK Direct, Hiscox; Vodafone (12 years); Andersen Consulting | — |
Paul Lawrence | CUO, Hiscox London Market; Active Underwriter, Syndicate 33 | Joined 1992; CUO since Apr 2013 | Syndicate 144; E W Payne | — |
Kathleen Reardon | CEO, Hiscox Re | Jan 2021 | CEO Hamilton Re (2014–20); ACE Tempest Re | BSc Mathematics (Drexel); FCAS |
“—” = not publicly disclosed.
Board of Directors
| Name | Role | Joined | Background |
|---|---|---|---|
Peter Clarke | Chair | 1 Jun 2025 (Chair from 1 Jul 2025) | Ex-Chair Lancashire Insurance Holdings; Chair of Redwheel; NED of Lombard Odier AM, AXA IM, Sainsbury's Bank |
Jane Guyett | Senior Independent Director | Sep 2024 | 15 years at Bank of America Securities (COO EMEA) |
Aki Hussain | Group CEO | — | See above |
Paul Cooper | Group CFO | — | See above |
Beth Boucher | Independent NED | May 2023 | Fortium Partners, SiriusPoint, Travelers, Pfizer, Accenture; NED Coforge |
Constantinos (Costas) Miranthis | Independent NED | Nov 2017 | Ex-President & CEO PartnerRe; FIA |
Donna DeMaio | Independent NED | Apr 2022 | Ex-Global COO General Insurance and Global Chief Auditor, AIG; CEO MetLife Bank |
June Yee Felix | Independent NED | Jan 2025 | Ex-Group CEO IG Group; Chase, Citi, Verifone |
Lynne Biggar | Independent NED | Jan 2025 | Ex-EVP & Global CMO Visa; American Express; Senior Advisor BCG |
Michael Goodwin | Independent NED | Nov 2017 | Ex-CEO QBE Asia Pacific; FIAA |
Thomas Huerlimann | Independent NED | Nov 2017 | Ex-CEO Global Corporate, Zurich; Swiss Re |
Board & Management Changes
| Date | Change |
|---|---|
Sep 2024 | Jane Guyett joins the Board (later SID) |
| 2024 | Mary Boyd joins as CEO, Hiscox USA |
Jan 2025 | Shali Vasudeva joins as Group COTO; June Yee Felix and Lynne Biggar join the Board |
1 Jul 2025 | Peter Clarke succeeds Colin Keogh as Chair |
| 2026 | Shirley Girling joins as Group General Counsel |
Jul 2026 | Aparna Sarin joins in the new role of Group Chief Marketing & Revenue Officer |
Major Shareholders
| Holder | Stake | Date / source |
|---|---|---|
Société Générale (shares plus CFDs) | 5.10% of voting rights (16,422,604) | TR-1, position as of 19 Aug 2026 |
Other TR-1 filers (Jan, Aug, Sep 2026) | Not identified in sources reviewed | RNS list shows TR-1s on 2, 9 and 15 Jan, 11 and 21 Aug, and 8, 9 and 21 Sep 2026 |
Remaining top-10 institutional holders | Not publicly disclosed in sources reviewed; see hiscoxgroup.com "Major shareholders" | — |
Competitive Landscape
Competitors by Segment
| Segment | Named competitors | Positioning versus Hiscox |
|---|---|---|
Retail – UK SME and professional | Intact Insurance UK (formerly RSA/NIG), Aviva, AXA UK, Allianz UK, Zurich UK, QBE, Markel UK, Travelers (Simply Business distribution) | Hiscox is a specialist brand with strong direct capability. Intact is the UK's third-largest commercial insurer with about 7% share. |
Retail – UK high net worth | Chubb, AIG Private Client Select, Ecclesiastical, Zurich Private Clients | Hiscox is a leading HNW specialist with NPS above 80 |
Retail – Europe | Allianz, AXA, Markel International, Chubb, CNA Hardy, Beazley/Zurich (cyber) | Hiscox is a niche leader in German professional lines and cyber |
Retail – US small commercial / digital | The Hartford, Travelers, Chubb, Next Insurance (now part of ERGO/Munich Re), Markel, Berkshire Hathaway (biBERK), Progressive (commercial) | Hiscox is a top-tier digital-direct small-business brand but sub-scale against Hartford and Travelers |
London Market / Lloyd's specialty | Beazley (being acquired by Zurich), Lancashire, Brit, Chaucer, Canopius, Markel, Arch, AXA XL, Chubb, Tokio Marine Kiln | Mid-sized, disciplined Lloyd's leader |
Reinsurance / ILS | RenaissanceRe, Arch, Everest, Hannover Re, Munich Re, Swiss Re, Lancashire, Nephila/Markel, Fermat, Securis | Mid-tier reinsurer with a fast-growing ILS franchise ($2.9bn AUM) |
Peer Comparison FY2025
| Metric | Hiscox | Beazley |
|---|---|---|
Written premium (USD Mn) | 4979.0 (ICWP) | 6100.7 (IWP) |
Premium growth (%) | 5.9 | -1.0 |
Profit before tax (USD Mn) | 732.7 | 1,146.5 |
Undiscounted combined ratio (%) | 87.8 | 81.0 |
Return on equity (%) | 17.1 | 19.0 |
Recent Developments
The Q3 2026 trading statement. Hiscox typically issues a nine-month statement in late October or early November.
Any H2 2026 North Atlantic hurricane loss estimates.
The change programme targets productivity through technology rather than declared headcount cuts.



